Showing results (421-430 of 521) with videos related to

Sort By:
Pageof 53
International Health|September 17, 2013
Knowledge, attitudes and practices survey after an outbreak of chikungunya infectionsM L Moro, C Gagliotti, G Silvi, et al.
Brain & Development|May 1, 1996
Leigh syndrome and partial deficit of cytochrome c oxidase associated with epilepsia partialis continuaM Elia, S A Musumeci, R Ferri, et al.
Journal of Pediatric Nursing|August 31, 2019
Effect of a Sedation Weaning Protocol on Safety and Medication Use among Hospitalized Children Post Critical IllnessJean C Solodiuk, Christine D Greco, Katherine A O'Donnell, et al.
European Journal of Cell Biology|October 24, 2000
Analysis of cadherin/catenin complexes in transformed thyroid epithelial cells: modulation by beta 1 integrin subunitA Celetti, C Garbi, C Consales, et al.
The Journal of Experimental Medicine|January 1, 1995
CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgER Paganelli, E Scala, I J Ansotegui, et al.
Leukemia & Lymphoma|April 28, 2000
Acute myeloblastic leukemia secondary to myelodysplasia (MDS-AML): a comparison of remission induction with three drugs versus standard two-drugs inductionR Latagliata, M Breccia, A Pulsoni, et al.
Journal of Immunological Methods|September 15, 1999
Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. European Concerted Action on Immunological and Virological Markers of HIV Disease ProgressionK S Froebel, N G Pakker, F Aiuti, et al.
Epidemiology and Infection|April 28, 2017
Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidenceC Signorelli, A Odone, V Ciorba, et al.
AIDS (London, England)|April 26, 2000
Cancer risk among men with, or at risk of, HIV infection in southern EuropeD Serraino, A Boschini, P Carrieri, et al.
The Journal of Infectious Diseases|October 23, 1997
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected personsM Carlesimo, O Pontesilli, E C Guerra, et al.
Pageof 53